Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Patient awareness and attainment of goals in Type 2 Diabetes Mellitus: A real-world survey

Patient awareness and attainment of goals in Type 2 Diabetes Mellitus: A real-world survey

Why has our brain suddenly become of interest?

Why has our brain suddenly become of interest?

IOPD Challenges

IOPD Challenges

Atherosclerosis: Identifying risks and improving outcomes

Atherosclerosis: Identifying risks and improving outcomes

Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice

Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice

Ticagrelor vs Clopidogrel in Older Patients With ACS PCI

Ticagrelor vs Clopidogrel in Older Patients With ACS PCI

Managing the Recurrent ASCVD Risks of Your ACS Patient: A call to Action – GULF Perspective: Part 3

Managing the Recurrent ASCVD Risks of Your ACS Patient: A call to Action – GULF Perspective: Part 3

Multidisciplinary approaches in Rare Disease Patient management in KSA

Multidisciplinary approaches in Rare Disease Patient management in KSA

Managing Recurrent ASCVD risk of your ACS Patient: A call to Action – GULF Perspective: Part 2

Managing Recurrent ASCVD risk of your ACS Patient: A call to Action – GULF Perspective: Part 2

Managing the Recurrent ASCVD Risks of Your ACS Patient: Gulf Perspective (Part 1)

Managing the Recurrent ASCVD Risks of Your ACS Patient: Gulf Perspective (Part 1)

The Bright Study

The Bright Study

Fabry Disease from Cardiology Perspective

Fabry Disease from Cardiology Perspective